Psoriasis drug showdown: which works better?
NCT ID NCT07337434
First seen Jan 14, 2026 · Last updated May 11, 2026 · Updated 19 times
Summary
This study compares two oral medications, methotrexate and apremilast, to see which is more effective for moderate to severe plaque psoriasis. About 106 adults aged 18-60 with no recent systemic treatment will be followed for 12 weeks. The main goal is to see which drug achieves a 75% reduction in psoriasis severity (measured by PASI score).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MTI-HMC Peshawar
RECRUITINGPeshawar, Khyber Pukhtunkhwa, 25000, Pakistan
Conditions
Explore the condition pages connected to this study.